Cinctive Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Cinctive Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,376	Closed	-$1.67M	–	395
2025 Q3	$1.67M	Sell	8,376 -838	-9%	-$156K	0.08%	269
2025 Q2	$1.59M	Buy	9,214 +1,574	+21%	+$256K	0.08%	245
2025 Q1	$1.19M	Buy	+7,640	New	+$1.09M	0.09%	199
2024 Q4	–	Sell	-11,271	Closed	-$1.68M	–	348
2024 Q3	$1.68M	Sell	11,271 -8,079	-42%	-$1.09M	0.09%	246
2024 Q2	$2.64M	Sell	19,350 -29,033	-60%	-$3.95M	0.13%	217
2024 Q1	$7.31M	Buy	+48,383	New	+$6.91M	0.34%	93

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cinctive Capital Management's ASND Position: Q4 2025 in Review

Cinctive Capital Management sold out of Ascendis Pharma A/S (ASND) in Q4 2025, closing a stake of 8,376 shares — an estimated $1.67M sold.

Cinctive Capital Management first reported a position in ASND in Q1 2024 and held it in 6 quarters. The position peaked at $7.31M in Q1 2024. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

Cinctive Capital Management reported no remaining Ascendis Pharma A/S position as of Q4 2025 after selling out during the quarter.
Cinctive Capital Management sold 8,376 Ascendis Pharma A/S shares in Q4 2025, an estimated $1.67M.
Cinctive Capital Management first reported a position in Ascendis Pharma A/S in Q1 2024 and held it in 6 quarters.
Cinctive Capital Management's Ascendis Pharma A/S position peaked at $7.31M in Q1 2024.
302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.